Crystalline forms of ethyl[3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetate

US11311014B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11311014-B2
Application numberUS-201816497938-A
CountryUS
Kind codeB2
Filing dateMar 27, 2018
Priority dateMar 31, 2017
Publication dateApr 26, 2022
Grant dateApr 26, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to crystalline forms of ethyl[3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetate (CAS 353292-31-6), herein after also referred to as “compound of formula (I)”.The invention also relates to a process for the production of these crystalline forms, formulations for plant protection and herbicidal compositions which contain one of these crystalline forms.

First claim

Opening claim text (preview).

The invention claimed is: 1. An ethyl[3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetate, consisting of at least 90 wt. % of the crystalline form A, which in an X-ray powder diffraction diagram at 25° C. and Cu-Kα radiation displays at least 3 of the following reflections, quoted as °2θ values: 10.42±0.10, 12.65±0.10, 16.64±0.10, 18.09±0.10, 18.44±0.10, 19.41±0.10, 22.17±0.10, 23.61±0.10, 24.06±0.10, 24.88±0.10, 25.20±0.10, 26.17±0.10, 27.86±0.10, 29.08±0.10. 2. The ethyl[3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetate as claimed in claim 1 , wherein form A displays at least 5 of the following reflections, quoted as °2θ values: 10.42±0.10, 12.65±0.10, 16.64±0.10, 18.09±0.10, 18.44±0.10, 19.41±0.10, 22.17±0.10, 23.61±0.10, 24.06±0.10, 24.88±0.10, 25.20±0.10, 26.17±0.10, 27.86±0.10, 29.08±0.10. 3. The ethyl[3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetate as claimed in claim 1 , wherein form A displays at least 7 of the following reflections, quoted as °2θ values: 10.42±0.10, 12.65±0.10, 16.64±0.10, 18.09±0.10, 18.44±0.10, 19.41±0.10, 22.17±0.10, 23.61±0.10, 24.06±0.10, 24.88±0.10, 25.20±0.10, 26.17±0.10, 27.86±0.10, 29.08±0.10. 4. The ethyl[3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetate as claimed in claim 1 , wherein form A displays the following reflections, quoted as °2θ values: 10.42±0.10, 12.65±0.10, 16.64±0.10, 18.09±0.10, 18.44±0.10, 19.41±0.10, 22.17±0.10, 23.61±0.10, 24.06±0.10, 24.88±0.10, 25.20±0.10, 26.17±0.10, 27.86±0.10, 29.08±0.10. 5. The ethyl[3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetate as claimed in claim 1 , consisting of at least 98 wt. % of the crystalline form A. 6. The ethyl[3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetate as claimed in claim 1 , consisting of at least 99 wt. % of the crystalline form A. 7. The ethyl[3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetate as claimed in claim 1 , consisting of 100 wt. % of the crystalline form A. 8. A herbicidal composition comprising a herbicidal active amount of the ethyl[3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetate as claimed in claim 1 , and at least one further active compound selected from B) herbicides of class b1) to b15): b1) lipid biosynthesis inhibitors; b2) acetolactate synthase inhibitors (ALS inhibitors); b3) photosynthesis inhibitors; b4) protoporphyrinogen-IX oxidase inhibitors, b5) bleacher herbicides; b6) enolpyruvyl shikimate 3-phosphate synthase inhibitors (EPSP inhibitors); b7) glutamine synthetase inhibitors; b8) 7,8-dihydropteroate synthase inhibitors (DHP inhibitors); b9) mitosis inhibitors; b10) inhibitors of the synthesis of very long chain fatty acids (VLCFA inhibitors); b11) cellulose biosynthesis inhibitors; b12) decoupler herbicides; b13) auxinic herbicides; b14) auxin transport inhibitors; and b15) other herbicides selected from the group consisting of bromobutide, chlorflurenol, chlorflurenol-methyl, cinmethylin, cumyluron, dalapon, dazomet, difenzoquat, difenzoquat-metilsulfate, dimethipin, DSMA, dymron, endothal and its salts, etobenzanid, flamprop, flamprop-isopropyl, flamprop-methyl, flamprop-M-isopropyl, flamprop-M-methyl, flurenol, flurenol-butyl, flurprimidol, fosamine, fosamine-ammonium, indanofan, indaziflam, maleic hydrazide, mefluidide, metam, methiozolin (CAS 403640-27-7), methyl azide, methyl bromide, methyl-dymron, methyl iodide, MSMA, oleic acid, oxaziclomefone, pelargonic acid, pyributicarb, quinoclamine, triaziflam, tridiphane and 6-chloro-3-(2-cyclopropyl-6-methylphenoxy)-4-pyridazinol (CAS 499223-49-3) and its salts and esters; including their agriculturally acceptable salts or esters thereof. 9. A plant protection agent comprising the ethyl[3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetate as claimed in claim 1 , and one or more additives customary for the formulation of plant protection agents. 10. The plant protection agent as claimed in claim 9 in the form of an aqueous suspension concentrate. 11. The plant protection agent as claimed in claim 9 in the form of a non-aqueous suspension concentrate. 12. The plant protection agent as claimed in claim 9 in the form of a powder or granules dispersible in water. 13. A method for combating undesired plant growth, wherein the ethyl[3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetate as claimed in claim 1 is used on plants, the habitat thereof and/or on seeds.

Assignees

Inventors

Classifications

  • C07D401/12Primary

    linked by a chain containing hetero atoms as chain links · CPC title

  • Crystalline forms, e.g. polymorphs · CPC title

  • Biocides, pest repellants or attractants, or plant growth regulators containing substances of unknown or undetermined composition, e.g. substances characterised only by the mode of action · CPC title

  • Ingredients for reducing the noxious effect of the active substances to organisms other than pests, e.g. toxicity reducing compositions, self-destructing compositions · CPC title

  • A01N43/54Primary

    1,3-Diazines; Hydrogenated 1,3-diazines · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11311014B2 cover?
The present invention relates to crystalline forms of ethyl[3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetate (CAS 353292-31-6), herein after also referred to as “compound of formula (I)”.The invention also relates to a process for the production of these crystalline forms, formulations for plant protection and herbicidal…
Who is the assignee on this patent?
Basf Se
What technology area does this patent fall under?
Primary CPC classification C07D401/12. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).